Recent Stories
American Biotech — The Future Can’t Be Won Without It.RSI is AI Building AI. What DC needs to know about it. Keeping the Human in Medicine: Two AI CoLab Researchers on What Machines Can’t ReplaceSomeone Is Hacking the Freezers. Pay Attention.Thinking of Running in 2028? Start HereWhat the Lame Duck Session Has to Do With the Ultimate 21st-Century Power Tool: Robots

The Wave

Senatein sessionHousein session
Refreshed just now
News

FDA’s search for a new leader, and China’s largest drugmakers

Why it’s here: Podcast episode centers on the withdrawn FDA commissioner nomination (a federal leadership/policy fight over biotech regulation) and a STAT index of China's largest drugmakers tied to BIOSECURE-style competition concerns, though it is a multi-topic episode bundling several items.

Trace across the board

Item

  1. 2d agoSTATFDA’s search for a new leader, and China’s largest drugmakersSTAT's Readout Loud podcast episode covers the Trump administration withdrawing Heidi Overton's FDA commissioner nomination, the FDA's rejection of Summit Therapeutics and Akeso's lung cancer drug, and STAT's new index ranking China's largest drugmakers.
    4 articles · 2 outlets
    1. 4d agoSTATSTAT+: White House pulls nomination of Heidi Overton to lead FDA
    2. 4d agoYahooPickupWhite House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans
    3. 3d agoSTATSTAT+: 7 burning questions about the FDA’s post-Overton future
    4. 2d agoSTATEarliestFDA’s search for a new leader, and China’s largest drugmakers
    Biotech66 linked

Coverage

2 outlets · first seen 4d ago

Connected

8 links

About

  • Senate
  • Food and Drug Administration
  • Heidi Overton

Analytics cookies help us see how the site is used. They only run if you accept. Privacy Policy